HeNan Genuine Biotech Sets Azvudine Price at RMB300 per Bottle for COVID-19 Therapy
China-based HeNan Genuine Biotech Co., Ltd has set the price of its COVID-19 therapy azvudine...
Sinotherapeutics Inc. to Raise RMB600m via STAR Board IPO for Generic Drug Expansion
Sinotherapeutics Inc., a Shanghai-based generic drug developer, is set to make an initial public offering...
CDE Issues Q&As on COVID-19 Antiviral Drug Evaluation Criteria
The Center for Drug Evaluation (CDE) has published a list of Q&As regarding the non-clinical...
NMPA Approves BioFire Diagnostics’ Encephalitis/Meningitis Detection Kit
The National Medical Products Administration (NMPA) website indicates that BioFire Diagnostics LLC’s encephalitis/meningitis multiple pathogen...
BioDuro-Sundia and X-Chem Form Long-Term Partnership for Drug Discovery
Two China-based companies, the Contract Research, Development, and Manufacturing Organization (CRDMO) BioDuro-Sundia and X-Chem, have...
Dizal Pharma’s Sunvozertinib Shows Promise in NSCLC with EGFR Exon 20 Insertion
China-based Dizal Pharmaceutical Co., Ltd (SHA: 688192) has unveiled the latest positive data for its...
Hywin Holdings to Acquire Life Infinity for Health Management Expansion
China-based wealth management firm Hywin Holdings is set to move into the health management business...
HutchMed’s FRESCO-2 Study for Elunate in Colorectal Cancer Meets Primary Endpoint
China-based Hutchison China Meditech (HutchMed; NASDAQ: HCM, HKG: 0013) announced that the pivotal global Phase...
Frontier Biotech Partners with Kindstar to Boost Anti-Infection Testing, Especially for HIV
China-based Frontier Biotechnologies Inc. (SHA: 688221) has entered into a partnership with compatriot firm Kindstar...
Innovent Biologics Doses First Subject in IBI324 Phase I Study for DME
China-based biotech Innovent Biologics Inc. (HKG: 1801) announced that the first subject has been dosed...
Immvira’s Oncolytic Virus MVR-C5252 Receives FDA Orphan Drug Designation for Glioma
Shenzhen-based Immvira Co., Ltd, a biotech company focused on oncolytic viruses, announced that it has...
Transcenta Appoints Dr. Caroline Germa as Global Drug Development Chief
China-based biotech Transcenta Holdings Ltd (HKG: 6628) announced the appointment of Dr. Caroline Germa as...
NHC Issues Notification on Medication Safety Management and Rational Drug Use
The National Healthcare Commission (NHC) has released a notification focusing on medication safety management and...
Ningbo Health Gene Raises Hundreds of Millions in Series C Financing
Ningbo Health Gene Technologies Co., Ltd, a China-based medical testing solution provider, has reportedly raised...
Intuitive Surgical-Fosun JV Breaks Ground on Shanghai Medical Robot Base
Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd, a joint venture (JV) between China-based Shanghai Fosun...
Bayer AG’s Q2 2022 Results Show Global Sales Growth Amid China VBP Pressures
Germany-based pharmaceutical giant Bayer AG (VIE: BAYN) released its Q2 2022 financial report, revealing a...
Intellective Biologics Raises Over RMB500m in Series C Financing Round
China-based macromolecule-focused Contract Development and Manufacturing Organization (CDMO) Intellective Biologics (Suzhou) Co., Ltd has reportedly...
MicuRx Pharmaceuticals Completes RMB1.06B IPO for Antibacterial Drug Development
Shanghai-based antibacterial drug developer MicuRx Pharmaceuticals has officially made an initial public offering (IPO) of...
invoX Pharma Extends Tender Offer for F-star Therapeutics to September 19
invoX Pharma Ltd, a UK-based subsidiary of China’s Sino Biopharmaceutical Ltd (HKG: 1177), announced that...
Merck Launches Prevymis, a Non-Nucleoside CMV Inhibitor, in China
US pharmaceutical giant Merck Sharp & Dohme (MSD, NYSE: MRK) announced the commercial launch of...